Stress Management Program for Caregivers of Dementia Patients
(MASC Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those who have recently changed their treatment for depression or anxiety.
What data supports the effectiveness of the treatment MASC for caregivers of dementia patients?
Research shows that stress reduction programs, like the integrative stress reduction program (ISRP) and mindfulness-based stress reduction (MBSR), can significantly decrease stress and improve sleep quality for caregivers of dementia patients. These programs have also been shown to reduce behavioral and psychological symptoms in dementia patients, suggesting that similar treatments like MASC may also be effective.12345
Is the Stress Management Program for Caregivers of Dementia Patients safe for humans?
The stress management programs mentioned, which include non-drug tools like animatronic pets and aromatherapy, are described as simple and safe for use at home. These interventions have been shown to reduce stress and improve sleep quality in caregivers, suggesting they are generally safe for humans.12678
How is the MASC treatment different from other treatments for caregivers of dementia patients?
What is the purpose of this trial?
Building on limitations of prior research, the investigators proposed to develop the Mindful and Self-Compassionate Care Program (MASC) to help caregivers of persons with Alzheimer Disease and Related Dementias (ADRD) manage stress associated with the general caregiver experience including stress stemming from managing challenging patient behaviors. MASC teaches: (1) mindfulness skills; (2) compassion and self-compassion skills; and (3) behavioral management skills. MASC also provides psychoeducation and group-based training and skill practice to facilitate skill uptake and integration within the caregiver experience and tasks.
Research Team
Ana-Maria Vranceanu, PhD
Principal Investigator
Massachusetts General Hospital
Christine Ritchie, MD, MSPH
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
This trial is for adults over 18 who speak English and have been unpaid caregivers to someone with Alzheimer's or dementia for at least 6 months, providing an average of 4 hours of care daily. They must be experiencing stress from caregiving, live with the care recipient, and have dealt with challenging behaviors recently.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in six virtual group sessions to learn mindfulness, self-compassion, and behavioral management skills, with at-home practice to integrate these skills into daily life.
Follow-up
Participants are monitored for stress, depression, anxiety, and well-being improvements post-intervention.
Treatment Details
Interventions
- MASC
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
National Institutes of Health (NIH)
Collaborator